| # | Drug | Count |
|---|---|---|
| 0 | ZOLEDRONIC ACID | 43 |
| 1 | DENOSUMAB | 42 |
| 2 | EXEMESTANE | 19 |
| 3 | FULVESTRANT | 17 |
| 4 | RIBOCICLIB | 16 |
| 5 | METHOTREXATE SODIUM | 8 |
| 6 | METHOTREXATE | 7 |
| 7 | ALENDRONATE SODIUM | 5 |
| 8 | ENALAPRIL | 5 |
| 9 | METFORMIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRASTUZUMAB-DKST | 1 | 0.0036 |
| 1 | IBANDRONATE SODIUM | 4 | 0.0013 |
| 2 | MEBENDAZOLE | 1 | 0.0013 |
| 3 | ZOLEDRONIC ACID | 43 | 0.0011 |
| 4 | EXEMESTANE | 19 | 0.0009 |
| 5 | RAMUCIRUMAB | 4 | 0.0006 |
| 6 | RADIUM RA 223 DICHLORIDE | 3 | 0.0006 |
| 7 | PAMIDRONATE DISODIUM | 2 | 0.0006 |
| 8 | SALICYLIC ACID 12% | 1 | 0.0005 |
| 9 | ASTRINGENT | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 4 | 0.0006 |
| 1 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 2 | Estrogen Receptor Antagonist [EPC] | 17 | 0.0004 |
| 3 | Anthelmintic [EPC] | 1 | 0.0003 |
| 4 | RANK Ligand Inhibitor [EPC] | 42 | 0.0002 |
| 5 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 6 | Aromatase Inhibitor [EPC] | 20 | 0.0002 |
| 7 | Chloride Channel Activator [EPC] | 1 | 0.0001 |
| 8 | Non-Standardized Plant Allergenic Extract [EPC] | 1 | 0.0001 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 1 | 0.0000 |